Marek Kania
Impact in
-
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
-
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 18
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
-
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Jalid Sehouli (3 shared papers)Annamaria H. Zimmermann (1 shared paper)Christopher Kaiser (1 shared paper)Hilary Calvert (1 shared paper)Ignace Vergote (2 shared papers)Arvind Dasari (6 shared papers)Gwénaëlle Gravis (1 shared paper)Heikki Joensuu (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (5 papers)Blood (3 papers)Investigational New Drugs (3 papers)Future Oncology (1 paper)
- Partner nations
- United StatesItalySpain
In The Last Decade
Marek Kania
23 papers receiving 192 citations
Peers
Comparison fields: 5 of 34
- Oncology 119
- Reproductive Medicine 35
- Pulmonary and Respiratory Medicine 66
- Genetics 14
- Surgery 56
Countries citing papers authored by Marek Kania
This map shows the geographic impact of Marek Kania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Kania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Kania more than expected).
Fields of papers citing papers by Marek Kania
This network shows the impact of papers produced by Marek Kania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Kania. The network helps show where Marek Kania may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Kania, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 40 | |
| 2 | 2009 | 40 | |
| 3 | 2021 | 31 | |
| 4 | 2020 | 15 | |
| 5 | 2013 | 13 | |
| 6 | 2010 | 10 | |
| 7 | 2023 | 7 | |
| 8 | 2011 | 7 | |
| 9 | 2009 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2020 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2021 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2008 | 1 | |
| 20 | 2019 | 1 |
About Marek Kania
Marek Kania is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Genetics and Surgery, having authored 26 papers that have together received 196 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Oncology (119 citations), Reproductive Medicine (35 citations), Pulmonary and Respiratory Medicine (66 citations), Genetics (14 citations) and Surgery (56 citations). Marek Kania has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Jalid Sehouli, Annamaria H. Zimmermann, Christopher Kaiser, Hilary Calvert, Ignace Vergote, Arvind Dasari, Gwénaëlle Gravis, Heikki Joensuu, Jan Lehmann and William R. Schelman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, Investigational New Drugs and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.